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We present a novel 3D hybrid assembly of a polymer microfluidic chip with
polycarbonate track-etched membrane (PCTEM) enabling membrane-supported cell
culture. Two chip designs have been developed to establish either diffusive or
convective reagent delivery using the integrated PCTEM. While it is well suited to a
range of cell-based assays, we specifically employ this platform for the screening of
a common antitumor chemotoxic agent (mitomycin C – MMC) on the HL60
myeloid leukemia cell line. The toxic activity of MMC is based on the generation of
severe DNA damage in the cells. Using either mode of operation, the HL60 cells
were cultured on-chip before, during, and after exposure to MMC at concentrations
ranging from 0 to 50lM. Cell viability was analysed off-chip by the trypan blue dye
exclusion assay. The results of the on-chip viability assay were found to be
consistent with those obtained off-chip and indicated ca. 40% cell survival at MMC
concentration of 50lM. The catalogue of capabilities of the here described cell assay
platform comprises of (i) the culturing of cells either under shear-free conditions or
under induced through-membrane flows, (ii) the tight time control of the reagent
exposure, (iii) the straightforward assembly of devices, (iv) the flexibility on the
choice of the membrane, and, prospectively, (v) the amenability for large-scale
parallelization.VC 2013 AIP Publishing LLC. [http://dx.doi.org/10.1063/1.4804250]
I. INTRODUCTION
Despite notable advances in the development of biomedical diagnostic devices and a large
market of currently established tools, there is a continuously growing demand for miniaturized,
low-cost1 devices that can accurately control in vivo conditions for cell culture, handling, and
analysis with minimum user intervention. If equipped with a set of key on-chip fluidic opera-
tions that are highly configurable and manufactured at low cost,1 these devices bear great prom-
ise in high-throughput, automated drug discovery2 and screening3 and also lend themselves for
point-of-care settings by relatively unskilled personnel. Ideally, such platforms should assist in
monitoring multiple aspects of cell physiology, be compatible to various types of cellular
assays, and, yet, provide a large degree of freedom in adjustment of experimental conditions
with reduced consumption of reagents and cells. Increasing the functionality of such systems
while, at the same time, adopting a standard chip format reduces the time and cost of manufac-
turing. Furthermore, this strategy opens an opportunity for further system-level integration with
bio-diagnostic tools characterised by a higher degree of complexity.
Prior to analysis of cell populations, the cells first need to be temporally isolated or con-
fined to a region that can be investigated on a chip. One of the common approaches for high-
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throughput cell trapping and sorting in microfluidic cell-based perfusion systems is to geometri-
cally restrict the location of the target cells by introducing a trench,4–6 microwell,7 trap,8 array
of geometrical cell restrictors,9,10 hydrogel-based scaffolds,11,12 and cell chambers.13 An alter-
native, simple, and comparatively rarely explored method is to introduce membrane-integrated
devices where an embedded biocompatible and porous membrane physically separates the cul-
ture compartment from the flow carrying microfluidic structures.14 Thus, the device simultane-
ously provides a means for controlling membrane-mediated drug transport and a support for
(long-term) cell culture experiments. Such hybrid integration of commercial, biocompatible
membranes with a homogeneous pore distribution already supports uniform cross-membrane
flow and a pressure drop across the culture wells, eliminating any further need for complex
flow homogenizers or fluid distributing networks.15
The membrane-to-chip assembly technology is widely covered in the literature and takes
its roots in microsystems for analytical chemistry where membranes in microreactors are used
for mixing, gas-liquid contacting, emulsification, filtration, sample purification, concentration or
pre-treatment, and adsorptive and other catalytic studies.16 The majority of these systems are
based on silicon technology or in situ synthesis of membranes17 and are used for the fabrication
of membranes with very specific properties—not always suitable to cell-based studies.
Moreover, in these cases, the manufacturing can be relatively complex, time consuming, and
pricy, thus seriously impeding the success of silicon- or glass-based fabrication processes in the
very cost-conscious bio-diagnostic arena. 3D polymeric hybrid systems with integrated mem-
branes for cellular assays constitute a relatively new research field demanding new engineering
concepts with a high degree of compatibility to established rapid prototyping technologies and
bio-samples.
As the membrane-assisted devices arose from traditional, bio-analytical applications over
the last decade,18 a variety of new chip devices for studying cells and biomimetic systems were
introduced. Among these are a perfusion system for high resolution microscopy on living
cells,19 chips performing Calcein-AM cell viability assays,20 assisting in integration of intestinal
epithelium,21 a bioreactor for monitoring kidney epithelial cells,22 systems for proteomic stud-
ies23 such as the trapping of lectin protein complexes,24 so-called organ-on-a-chip systems25
(which mimic, for instance, the physiology of human lung26 and blood vessels27), devices for
studies of bacterial chemotaxis28 and aerotaxis,29 and systems applied to the study of thrombo-
sis and hemostasis.30 Additionally, membranes were shown useful as a mask for direct pattern-
ing of proteins.31 The majority of the above mentioned systems are based on cast-moulded
Polydimethylsiloxane (PDMS) and are therefore quite limited in fabrication throughput, shelf
life, as well as their range of compatible solvents and chemical reagents. Also, these systems
were primarily designed to address one particular application, thus lacking a generic concept
suitable for a range of different cell-based assays.
Various technological approaches have been demonstrated for direct integration of poly-
meric membranes, such as gluing,32 sandwiching,19 clamping33 between flexible PDMS or rigid
polymeric materials, or direct in situ fabrication as a part of a microfluidic device using 3D
printing technology.34 However, such direct incorporation of commercial membranes with com-
monly used polymeric materials still remains technologically challenging. The main obstacles
lie in the sealing step due to the anti-sticking properties of the majority of rapid prototyping
polymeric materials and excessive membrane thickness or fragility. As a result, poor sealing
may lead to leakages or poor control over device performance. Another particular difficulty is
the reproducibility in manufacturing (particularly for the membranes which are only tens of
microns in thickness) while meeting the need for a sterile cell culture environment and ensuring
consistent flow conditions across the parallelized cell culture chambers during device operation.
In the present paper, we describe the design, fabrication, and operation of a microfluidic
platform for cell-based assay studies in various flow regimes. The performance of the system is
demonstrated by long-term culturing of HL60 human leukemic cells, whilst controllably expos-
ing the cells to a dilution series of a cytotoxic drug, the cellular exposure of which can be esti-
mated via an off-chip toxicity assay. The platform is based on mass manufacturable poly
(methyl methacrylate) (PMMA) chip base and biocompatible, polycarbonate track-etched
034101-2 Vereshchagina et al. Biomicrofluidics 7, 034101 (2013)
membranes (PCTEMs); these constituents are sealed via adhesives. The advantage of the here
presented assembly process is its simplicity as well as its amenability to a comprehensive cata-
logue of application-specific commercial membranes, e.g., featuring specific porosities, thick-
nesses, and morphologies. Therefore, a variety of applications and bioassay readout schemes,
for instance colorimetric or fluorimetric, can be implemented by the choice of the membrane.
Two fluidic designs and corresponding modes of operation are investigated in this paper and
supported by computational fluid dynamics (CFD) modelling. The suitability of the platform for
cell-based assays was demonstrated with a pilot study on the on-chip cultivation of HL60 with
a directed and controlled exposure to a chemotoxic drug mitomycin C (MMC).35 The results of
cell viability assays performed on-chip are in good agreement with those obtained from a stand-
ard microtiter plate. The actual cell seeding and cultivation took place on-chip and only the
detection was off-chip. Alternative types of perfusion systems require that cells be seeded in a
microtiter plate and only then transferred to the system for further analysis, which implies a
longer and more complex experimental procedure.15
The primary potential of the biomimetic system lies in the simplistic integration of any
type of bio-compatible transport control system by means of a thin membrane into a rigid
microfluidic system made of PMMA, as well as the simple, low-cost, and flexible system fabri-
cation and assembly process. The developed platform demonstrates reproducible performance in
both operation regimes and is deemed suitable for a wide range of cellular bioassays.
Throughout the following sections, we discuss the operational principle of the two
membrane-based platforms supported by the CFD modelling, the fabrication procedure, and the
results of the HL60 cell viability assay carried out using this platform. The paper is intended to
provide sufficient background information on design and fabrication aspects of hybrid poly-
meric membrane-based microfluidic platforms suitable for various cellular studies.
II. WORKING PRINCIPLE AND APPLICATION
The 3D schematic featuring the basic working principle of the two implemented microflui-
dic platforms—flow-through and diffusion-based—is illustrated in Figure 1. Each chip is com-
posed of a top sealing layer containing the aeration holes (Fig. 1(a)), a bottom fluidic part
integrating the cell-culture wells, the fluidic supply channels, and the interspersed membrane in
FIG. 1. Schematics of all constituent layers [(a)-(c)] and modes of operation [(d)-(e)] of the two developed fluidic design
concepts: top part of the chip containing holes for access to cell culture and gas recirculation (a), bottom part of the chip con-
taining a fluidic channel, a membrane, and a well before sealing with the top part for the flow-through (b) and diffusion-based
(c) designs, operational principle shown on example of a single well for flow-through (d) and diffusion-based (e) platforms.
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the configuration for the convection (Fig. 1(b)) and diffusion mode (Fig. 1(c)), respectively.
The low-dead-volume polycarbonate membrane with pore sizes ranging between 0.015 lm and
0.4 lm plays two critical roles in this study: first, it serves as a cell culture support and physical
barrier for suspended cells against contaminants. Second, the membrane permits continuous and
controlled exposure of the cells to various concentrations of a (media diluted) chemotoxic agent
which is originally introduced through a channel beneath the membrane. The gas concentrations
result from the interplay between the aeration through the access holes in the lid and the gas
dissolved in the supplied liquid, as, for instance, shown previously in experiments where
hypoxic conditions on cells are induced.36
We investigated two modes of operation. The first—governed mainly by the convective
mode of operation (Figures 1(b) and 1(d))—is designed for rapid exposure of the cells to the dis-
solved chemical agents. In this case, the flow (with a defined concentration of chemotoxic agent
in media) is forced from dead-ended polymer channel through the membrane into the suspended
cell culture. Provided there is sufficient resistance at the aeration holes, the media will traverse
the membrane towards the outlet channel. The exposure dose of a chemical agent depends on the
flow rate and the diameter of both areas of the membrane that are subjected to cross-membranous
flow when all other design parameters and membrane properties are kept constant.
The second mode (Figures 1(c) and 1(e)) is designed for long-term exposure by gradual
diffusion of a chemotoxic agent through the porous membrane. In this case, the media with
chemotoxic agent is supplied via the underlying channel and only allowed to diffuse through
the pores of membrane towards the cell culture. The rate of exposure to a chemical agent
depends on the flow rate and height of the out-flow channel when all other design parameters
and membrane properties are kept constant.
The limiting fluidic resistances, design considerations, and relevant application in the case
of both fluidic designs are discussed in more detail in the CFD modelling section in Sec. IV.
III. MATERIALS AND METHODS
A. CFD modelling
The CFD simulation was performed using the COMSOL MULTIPHYSICS 4.2a (COMSOL Group,
Sweden). The following modules were used: laminar flow in transient mode, free and porous
media flow, and the transport of diluted species in convection and diffusion modes. The first
and second modules were used to define the flow parameters and the latter to assess the distri-
bution of a drug within the culture well over time. In either mode, i.e., flow-through and
diffusion, the transient flow profile was first calculated. After steady-state was established, a
concentration step at the inlet was initiated and the advancement of the concentration profile in
time inside a culture well was monitored. The dimensions and modelling parameters are sum-
marized in Figure 5 and Table I of Appendix A. The values for permeability of the membrane
were taken from the WHATMAN
VR
website.37
B. Fabrication of the prototype
The prototypes were designed using AutoCAD 2012 and Solid Works 2011. Polymer rapid
prototyping techniques were applied for reproducible integration of the membrane inserts into
3D PMMA platforms. The materials used for manufacturing of microfluidic prototypes were
1.5-mm thick PMMA (Radionics, Ireland) and 175-lm PMMA sheets (Goodfellow, UK), and
86-lm thick pressure sensitive adhesive layers (PSA, Adhesive Research, Ireland). The 175-lm
and 1.5-mm thick PMMA sheets serve as “spacers” to increase the height of the fluidic chan-
nels and cell culture reservoirs, respectively, and to define the desired fluidic shape.
Additionally, the 1.5-mm thick rigid PMMA sheets are a convenient substrate for the assembly
of the thin and flexible membranes. We chose Cyclopore and Nucleopore WHATMAN (GE
Healthcare, UK) membranes with pore sizes of 0.1 lm, and the majority of the cell culture
experiments presented further was based on this membrane type. However, in the fluidic tests,
we have adopted other porosities as well: 15 nm, 0.2 and 0.4 lm.
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All layers shown in Figure 2(a) were machined individually. The 1.5-mm thick PMMA
sheets were cut by a CO2 laser ablation system (Zing 16 Laser, Epilog, USA) in the shape of a
base layer to which all the following layers are aligned using alignment holes and pins, cell cul-
ture chambers for subsequent fixing of the membranes, and a cover layer. The PSA, 175-lm
PMMA, and PCTEMs were cut by a standard knife plotter (ROBO Pro cutter/plotter, Graphtec,
USA) featuring all interconnecting fluidic structures, the fluidic channels, and the required cross
section (8 to 10mm) of the cell culture chamber, respectively.
The layers constituting the prototype can be broken down into three functional areas
(Figure 2(a)): (i) fluidic layer with a channel and a layer defining the flux area through the
membrane for controlled transport of nutrients; (ii) culture wells, i.e., reservoirs for seeding the
cells on the membrane; (iii) inlet/outlet area allowing access to cell culture samples as well as
recirculation of gas through the chambers.
Prior to assembly, the PMMA parts were cleaned using 2% Micro 90 solution (Sigma-
Aldrich) and blow-dried with a nitrogen gun. In order to ensure sterility of the cell assay chip, the
PCTEMs were autoclaved at 120 C for 20min and subsequently inspected by High-Resolution
Scanning Electron Microscopy (HRSEM) to exclude negative influence of autoclaving conditions
and UV treatment and to ensure structural integrity after the assembly (Figures 2(d) and 2(e)).
The 17 aeration holes of 0.7mm in diameter are evenly distributed around the cell culture
well of the top assembly layer to allow for sufficient gas exchange and access to cell culture at
all time.
To create the final device, all layers were stacked and aligned using a custom-made assem-
bly jig shown in Figure 2(b) under sterile conditions using UV light. The layers are then irre-
versibly bonded by means of the PSA at room temperature (shown in Figure 2(b) for the case
of devices featuring three wells). An alternative approach for assembly involved micro-milling
FIG. 2. Break-out of all functional layers (a); a photograph of the assembly process and an alignment jig (b); a photograph
of an assembled device during the fluidic test (c); HRSEM image of the polycarbonate membranes before (d) and after (e)
autoclaving and UV treatment; a photograph of a culture well loaded with cells after 24 h incubation at 37 C and 5% CO2
atmosphere (F).
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the channels in the thick PMMA sheets similar to those shown on the device in Figure 2(b) in
order to reduce the number of layers. The assembled platform (Figure 2(c)) has the convenient
format of a microscopy slide (25mm 75mm) that facilitates analysis of cultivated cells by
standard microscopy methods.
The devices were leak-tested using the computer controlled base module and the low
pressure pumping units from neMESYS (Cetoni, Germany), food colour dyes diluted in water,
bondable 400 Series Barb fluidic connectors (Value plastics, Inc.), and 1.5-mm diameter
Tygon tubing (Saint-Gobain Performance Plastics, France) for the flow rates ranging from 5
to 500 ll min1.
C. Trypan blue cell viability assay
The HL60 (Human myeloid leukemia) suspension cells were grown in RPMI-1640 medium
with 10% FBS, 2mM L-glutamine, and 1% penicillin-streptomycin. Following sub-culture, cells
were allowed to proliferate in suspension for 48 h prior to on-chip seeding at 37 C and 5%
CO2. When the cells reached a density of ca. 7.5  106 cells per ml, they were removed from
culture flasks and transferred to the experimental chip.
The cells were seeded via aeration holes in the top layer and incubated on-a-chip, and a
second culture was also seeded to a sterile 96-well microtiter plate for 24 h and 48 h. To verify
that the PCTEMs themselves do not influence the viability of cells or the efficacy of the MMC,
cells on the microtiter plate were cultivated in the presence and absence of a PCTEM at the fol-
lowing concentrations of MMC in media: 0, 3, 5, 10, 25, and 50 lM. The wells without the
PCTEM and those without MMC were used as negative controls for examining the potential
influence of the membrane material and the media on cell viability following MMC exposure,
respectively. The cell viability results obtained from the microtiter plate were used as a stand-
ard calibration curve and for further comparison of assay results obtained from the chip.
For the on-chip experiment, the cells were perfused with culture media containing appropri-
ate concentrations of MMC for 5min and 30min in the flow-through and diffusion-based plat-
forms, respectively, and then transferred to a standard cell culture CO2 incubator for 24/48 h at
37 C and 5% CO2. Following incubation, the cells were removed from the chip and a Trypan
Blue dye exclusion viability assay was applied to the cells. A 50-ll aliquot of the removed cells
was added to a tube containing 50 ll of Trypan Blue (Sigma Aldrich, MO, USA) and mixed
briefly by pipetting up and down twice. An 8-ll volume of this mixture was then placed in a
Bright-Line Hemocytometer (Sigma Aldrich, MO, USA) and inspected with an Olympus IX71
inverted microscope in bright-field mode (Olympus, Tokyo, JP). Viable cells were displaying as
white or pink, while non-viable cells were appeared as dark or deep blue. Cell viability was
reported as the percentage of viable vs the total cells count. All experiments were repeated at
least 5-fold.
IV. RESULTS AND DISCUSSION
A. Operation of platforms and design considerations
Two fluidic concepts—the flow-through platform (Figures 1(b) and 1(d)) and diffusion-
based platform (Figures 1(c) and 1(e))—were implemented, and the corresponding cross-
sectional views with equivalent fluid resistance schemes are shown in Figures 3(a) and 3(b)
(the limiting fluidic resistances in each scheme are highlighted in blue). In the sections below,
the fluidic design, specific conditions imposed on cultured cells, time scale on which exposure
to a chemotoxic agent is typically achieved, and potential application are discussed for each
platform. In terms of the application, the cells can be subjected to either rapid or slow alterna-
tions of chemical exposures when using the two platforms.
1. Flow-through mode
The flow-through platform enables combined transport of a chemical agent by both diffu-
sion and convection, the latter of them being dominant. The pressure drop in this system is a
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function of the fluidic resistances of the out-flow channel and the cross-membrane out-flow—
Routlet and Rmemb,out (highlighted in blue in Figure 3(a)), and the flow rate at which a diluted
chemical agent is supplied. Careful considerations of the above mentioned parameters will
allow a sufficiently high hydrostatic pressure and the desired liquid volume of cell medium
inside the well, as well as fine control over the rate of exposure to a delivered chemical agent
FIG. 3. Operational principle and the fluid resistance schemes (the limiting fluidic resistances are highlighted in blue) for
flow-through platform (a) and diffusion-based platform (b); the development of concentration profile inside the wells with
time for the flow through (c) and diffusion-based (d) platforms; the dependence of a liquid level inside a culture well on the
flow rate and the characteristic dimensions of the fluidic structure or the flow through (e) and diffusive (f) platforms (diame-
ter of the membrane cross section and height of the outlet channel for the flow through and diffusive platforms, respec-
tively) during the device operation, the dependence of normalized concentration profile inside a culture well on time of
both platforms (G).
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and gas exchange. The kinetics of mass transfer within this system occur on the scale of sec-
onds and the uniform concentration of diluted species inside the culture well can also be
achieved within seconds (Figures 3(c) and 3(g)). The CFD simulations in Figure 3(c) show that
the uniform chemical concentration inside the well of the flow-through platform is achieved
within less than 15 s.
Figures 3(e) shows the liquid level inside the well as a function of flow rate and diameter
of the membrane area through which the flow is passing towards the outlet. The height of the
liquid in the well is dependent on the equilibrium between the hydrostatic pressure in the well,
the pressure drops across the outlet membrane, and the outflow channel (see Eqs. (B1) and
(B2) of Appendix B). The liquid is supplied at a constant flow rate through the entire structure.
The liquid viscosity and the permeability of the membrane are constant for a given system;
therefore, the liquid level inside the well is controlled by the ratio of volumetric flow rate and
cross-sectional membrane area of the outflow (see Eq. (B3)). If a low volume of culture me-
dium and, correspondingly, a low liquid level in the well are desired, the cross-sectional area of
the membrane should be increased and the flow rate reduced. As an example, for a flow rate of
500 lm min1 and a desired liquid height of 1mm, the diameter of the outlet membrane should
be approximately 2mm. If higher flow rates and a smaller cross-sectional area for the cross-
membrane drug transport are to be established, liquid escape through the aeration holes has to
be prevented. This can, for instance, be implemented by increasing the height of the well by
hydrophobization38 of the access holes or simply by covering the upper holes with a removable
tape for the time the flow is applied.
As a result of cell respiration, carbon dioxide emerges an unavoidable by-product. It is
removed by the liquid flow and via the vents in the cover (Figure 1(a)). In terms of the oxygen
feed, one has the option of oxygen saturation through the vents in the cover or by the saturation
of the liquid feed entering the well. The former (used in this study) ensures sufficient oxygen
saturation of the entire well only if the liquid flow rate and the liquid height in the well are
low. By the latter pre-saturation of the supplied media, the oxygen is supplied via the liquid
flow passing the well.
We envision that the flow-through platform is well suited to applications where rapid
changes of specific feed compositions or high dosing levels are required, possibly in combina-
tion with shear-stress studies on cells. These 3D assays might be biologically more relevant
compared to the 2D systems introduced earlier for studying shear stresses on cells.39 Compared
to other systems demonstrated previously, e.g., based on hydrogel scaffolds11,12 and targeting
similar application, the present design ensures distribution of cells in the individual membrane-
supported chambers with no risk of cross contamination during parallel and rapid exposure of
cells to reagents. The reagents are fed via the channel and through the membrane where the
cells are directly seeded, resulting in more homogeneous exposure to chemotoxic agents com-
pared to the systems where reagents are fed from the side and rely on diffusive processes.13
Also, due to the purely fluidic nature of the strategy used to introduce a given concentration of
chemotoxic agent onto cells, a range of permitted liquid reagents is limited only by compatibil-
ity of the constructing materials, e.g., the electrochemically driven gradient generating systems
involving a bipolar membrane11 may require careful selection of liquid reagents as well as tedi-
ous calibration of experimental conditions.
2. Diffusion mode
In the case of diffusion platform featured in Figure 3(b), the cells are not exposed directly
to the flow, and transport occurs exclusively via diffusion through the membrane. As shown by
the development of a chemical concentration profile inside the well with the CFD simulations
in Figures 3(d) and 3(g), the lack of the convective mass transport extends the time for reaching
uniform concentrations to the minute scale, thus making the system more suitable for gradual
chemical exposures. There is no shear stress induced on cells during operation.
In the fluidic resistance scheme shown in Figure 3(b), the liquid flow is split according to
Eq. (B4) of Appendix B. A lower height in the channel below the membrane corresponds to
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both a higher flow resistance and, hence, increased convection through the membrane. Using
channel heights of 100 lm or more, the cells are not exposed directly to flow, and transport to
and from the well is limited to cross-membrane diffusion.
The liquid height in the well is governed by the pressure drop through the outlet channel
(see Eq. (B5)). Figure 3(e) shows the liquid level inside the well as a function of both the flow
rate and the height of the outflow channel. So at a given flow rate, reducing the height of the
out-flow channel increases the liquid level inside the culture well. Obviously, the increase in
flow rate raises the liquid level in the well.
During the chip perfusion, drug-containing medium that did not cross the membrane is led
to the waste. Therefore, for optimum usage of the drug, diffusion pathways should be mini-
mized, e.g., by a low-thickness membrane and small height of the feed channel. A high mass
transport is fostered by a steep concentration gradient across the membrane.
The height of the outlet channel can be designed based on a given flow rate and a desired
liquid height inside the well as illustrated in Figure 3(f). Here, we assumed an outlet channel
width of 1mm and a length of 10mm. The liquid height is one order of magnitude lower using
the diffusion-controlled design. To increase the liquid height as an alternative to changing the
channel dimensions, the flow restrictors downstream of the outlet channel can be used.
The exchange of oxygen and carbon dioxide required for cellular respiration is attained
via both aeration vents in the cover and by diffusion through the membrane. The time
required to establish the uniform distribution of a drug inside the well is often sufficient
for the gas exchange, as the metabolism of the cell is slow compared to the diffusion of
components using typical chip dimensions. This platform brings about slower changes of the
concentration profile but also results in very homogeneous concentration profiles of gas com-
pounds across the well. In our opinion, this makes the system more suitable for experiments
where gradual changes of the cell environment are of interest, and hydrodynamic shear stress
ought to be avoided.
In either operating mode, the system can be up scaled to multi-well compatible format
without increasing the complexity of the current fabrication procedure. This would allow an
automatized analysis of cellular assays on standard laboratory equipment,40 thus making it com-
petitive against some other recently demonstrated systems.13
B. Fabrication and membrane integration aspects
In Figures 2(d) and 2(e), the HRSEM images of the polycarbonate membranes are shown.
The pores are quite evenly distributed and oriented vertically through the entire thickness of the
membrane which (given a good seal by PSA) prevents any lateral leakage after assembly.
Furthermore, straight channels ensure low diffusion lengths and higher drug gradients. The
membranes have a very low internal pore volume (pore diameter 0.015lm–0.4 lm) and there-
fore also a low internal dead-volume (inside the pores of membrane). The membrane porosity
affects the dynamics of reagents delivery as flow resistance is alternated (increased with
increase of pore size). The pore size of 0.1 lm was used in the majority of cell based experi-
ments to prevent blocking of the pores by the migration of cells into the membrane. A number
of tests were carried out to verify the influence of sterilisation procedures on membrane mor-
phology and to ensure the pores are not blocked after high temperature and UV treatment. As
follows from HRSEM analysis, the membranes did not modify their morphology. The chosen
PCTEMs are hence suitable for sterilisation by means of UV-irradiation as well as temperature-
assisted assembly processes. The purchased membranes exhibited extremely hydrophilic proper-
ties, with a membrane-water-air contact angle of ca. 15.
Figure 2(c) shows the assembled device being leak tested with three colours of dyed water.
Two types of assembly were tested with thick (150 lm) and thin (25 lm) membranes.
In the case of the first membrane integration approach, the PCTEMs were placed on
PSA rings inside a shallow trench (ca. 0.5 mm deep) engraved in the middle PMMA layer by
a laser. Up to 150 lm thick cellulose membranes sealed by this method resulted in leakage-
free operation. However, the reproducibility of the procedure for placing the membranes in
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this case was limited by the quality of the engraving procedure for the trench with a laser, in
particular regarding the reproducibility of the trench height and the roughness of the surface.
Typically, the variation in thickness of the laser-engraved structures is in the order of tens of
microns.
In a second approach, suitable for thinner membranes, the 25-lm thick membranes were
sealed between the PMMA layers only using an adhesive film. In this case, the laminate inter-
face between the membrane and the PMMA substrate was characterized by an excellent adhe-
sive bond, and no leakage was observed during the operation. In cellular experiments, only the
devices with 25-lm thick membranes were used.
During the experiments with the flow-through design, it is important to apply hydrophobic
coatings (similar to those discussed elsewhere38) to the gas openings to prevent liquid escape
through the holes at higher flow rates due to capillary force as the liquid level in the well rises
(Figure 2(f)).
FIG. 4. Results of the viability test on HL60 following exposure to toxic MMC and incubation at 37 C and in 5% CO2
atmosphere for 24/48 h: optical microscopy images of cell samples 0 lMMMC (a), 50lMMMC (b) incubated off-chip for
comparison and 0lM MMC (c), 50 lM MMC (d) taken after incubation on-a-chip; results of the viability test on HL60
with MMC for the diffusion-based platform for MMC concentrations ranging from 0 to 50lM (e).
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C. Viability assay
To demonstrate feasibility, we carried out an in vitro cell viability assay by controlled incu-
bation of human HL60 cells with MMC35 on our microfluidic platform. As described in
Sec. III, the incubation was performed on-chip, while the experimental endpoint (a Trypan Blue
dye exclusion viability test) was run off-chip. Figure 4 shows the images of the cells before
and after the MMC treatment for samples taken from a cell assay performed in a microtiter
plate run in parallel to the on-chip experiments (Figures 4(a) and 4(b)) and a chip (Figures 4(c)
and 4(d)) incubated at the same conditions.
No deterioration or microbiological contamination was observed after the 48-h on-chip
incubation, thus confirming that the sterilization procedure was successful and chips are suitable
for long-term cell culture. The change in colour of the culture media from red to slightly yellow
inside the well indicates a lowering of the pH in the media and is due to the phenol red acid/
base indicator included in the media. Such a pH change is not uncommon in cell culture.
However, the significantly lower volume of the culture in this case, as well as the limited
capacity for gas exchange through the roof of the chip, may lead to an accelerated build-up of
carbonated acids in the media. Therefore, more openings were included on the top of the chip
to allow more active gas recirculation.
Figures 4(e) and 4(d) show a comparison of the viability assay performed on the diffusion-
based platform with the PCTEMs of 0.1 lm porosity for the concentrations of MMC ranging
from 0 to 50 lM off- and on-chip; the off-chip conditions show the viability data following cul-
ture either in the presence or absence of PCTEMs. Figure 4(e) demonstrates that higher viabil-
ity was observed in the on-chip strategy for all MMC exposures at 24 h of incubation compared
to a microtiter plate. The curves representing the viability after incubation with and without
membranes are coherent; thus, it is evident that the presence of the membrane itself does not
introduce a level of protection to cultured cells and is unlikely be a cause of the higher viability
observed from the experiments on chip. Therefore, we believe this may indicate partial pore
blockage by sedimenting cells resulting in delaying homogenous diffusion of the MMC. Also,
the fact that the sample is manually removed from the chip in order to perform the Trypan
Blue assay may introduce an error. We have, however, planned to upgrade the viability read-
out of the system to use a fluorescent or luminescent viability assay (such as CellTiter-Fluor
assay from promega) in situ on-chip. Such an upgrade will eliminate errors arising from off-
chip analysis. The data obtained from the cells that were incubated for 48 h (Figure 4(f)) corre-
spond well to the results obtained from the microtiter plate for the MMC concentrations from 0
to 10 lM, however, showing decreased viability at 30 and 50 lM MMC. Also, the results of
48 h incubation off-chip show notable difference between tests that include or exclude the pres-
ence of a PCTEM. This result was confirmed by repeating the experiment 5 times. We do not
yet have a clear explanation to this effect; however, on-going experiments are investigating the
effect further. No difference in performance was observed when membrane type (Cyclopore vs.
Nucleopore) was changed.
V. CONCLUSIONS AND OUTLOOK
In the present paper, we describe a 3D hybrid microfluidic platform with integrated GE
WHATMAN polycarbonate track-etched membranes enabling controlled cell culture and
screening of chemotoxic reagents. We discussed the design and fabrication as well as convec-
tion and diffusion modes of operation for the analysis platform. In both concepts, we success-
fully demonstrated on-chip incubation of HL60 myeloid leukemia cells and screening of MMC
exposure at concentrations between 0 and 50lM. The results of the on-chip viability assays
were well consistent with a standard curve obtained off-chip and, as an example, indicated ca.
40% survival rate at MMC concentration of 50 lM.
Forthcoming tests will expand the chip to allow multiplexing of chemotoxic exposures on
cultured cells as well as rapid testing of combinations of sub-lethal drug doses of complemen-
tary agents. The objective of a future prototype is to allow clinicians to investigate the effect of
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chemo-combination therapies to minimize overall agent doses for optimum cancer treatment.
The conceptual simplicity, ease-of-operation, flexibility, and low-cost of the here established
system make it well suited for hospital settings, doctor’s offices, and remote environments
where preliminary cell screening of prescribed drugs is to be performed by unskilled users.
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APPENDIX A: GEOMETRIES OF THE FLOW-THROUGH AND DIFFUSIVE PLATFORMS
WITH THE CORRESPONDING DIMENSIONS USED IN CFD MODELLING
A 2D representation of the microfluidic platforms with the corresponding dimensions used in
CFD modelling are provided below.
TABLE I. Parameters used in the CFD modelling for the flow-through and diffusive platforms.
Parameter Value Description
u 5 cm s1 Flow velocity
c 1mol m3 Normalized concentration of a drug at the inlet
T 293.15K Temperature
hin-ch¼ hout-ch 250lm Height of the channels for the flow through design
hout-ch
a 100lm Height of the outflow channel for the diffusive design
Lch 15mm Length of the channel
Lm 10mm Total length of the membrane
Lg
a 2mm Length of the membrane not exposed to flow
hm 25lm Thickness of the membrane
Lw 10mm Length of the culture well
hw 1mm Height of the culture well
k 1.231014 m/s Permeability coefficient37
aLimiting fluidic resistance in the system.
FIG. 5. Geometries of the flow-through (top) and diffusive (bottom) platforms.
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APPENDIX B: CALCULATION OF LIQUID LEVEL INSIDE CULTURE WELL
Liquid level inside the well for the flow through platform (shown in Figures 1(b) and 1(d))
Phydrostatic ¼ DPmemb;out þ DPch;out; (B1)
qgHliquid;well ¼ Qmemb;out  l  hmemb
kmemb  Amemb;out þ
8  l  Lch;out  Qch;out
p  R4ch;out
; (B2)
Hliquid;well ¼
Qmemb;outlhmemb
kmembAmemb;out þ
elLch;outQch;out
pR4
ch;out
qg

Qmemb;outlhmemb
kmembAmemb;out
qg
: (B3)
Liquid level inside the well for the diffusion-based (shown in Figures 1(c) and 1(e)):
Rch ¼ Rmemb;in þ Rwell þ Rmemb;out  Rmemb;in þ Rmemb;out; (B4)
Hliquid;well ¼
elLch;outQch;out
pR4
ch;out
qg
; (B5)
where Pi is the pressure, g is the acceleration due to gravity, q is the density of the liquid, Hi is the
height of liquid, Qi is the volumetric flow rate, l is the dynamic viscosity, hi is the thickness, Ai is
the cross-sectional area, Li is the length, kmemb is the permeability of the membrane, and Ri is the
resistance to flow.
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